🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dementia, Alzheimer Type

Dynamic Light Scattering Ocular Measurement in the Detection of Dementia NCT06613971n/a1 site📍 Coconut Creek MD Stem Cells Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease. NCT07467460n/a1 site📍 Pozzilli Neuromed IRCCS The Effect of Combination of Mediterranean Diet and Oleocanthal in Patients With Mild Cognitive Impairment NCT06705738NA2 sites📍 Thessaloniki📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: SUPOL, Dietary Pattern: MeDi The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3) NCT05885295n/a1 site📍 London Imperial College London · Tests: MRI brain, Blood tests, cognitive assessments Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)" NCT03890861NA1 site📍 Baton Rouge Pennington Biomedical Research Center · Tests: Physical activity, Successful Aging A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation NCT06647498Phase 2, Phase 337 sites📍 Birmingham📍 La Jolla📍 Los Angeles Washington University School of Medicine · Tests: Remternetug, Matching Placebo (Remternetug) Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital Paper-Based and Smartphone-Based Memory Supports NCT06444841NA3 sites📍 Austin📍 Temple📍 Waco Baylor University · Tests: Digital - Google Calendar, Paper-based - Memory Support System Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study) NCT06965062NA1 site📍 Singapore Vincent Tay Khwee Soon · Tests: Deep cervical lymph node to venous bypass (DCLNV-BP) PROMIS and Mobility Evaluation in Sarcoma Patients NCT07227961n/a4 sites📍 Phoenix📍 Rochester📍 Calgary University of Calgary · Tests: Surgery Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia NCT04240561NA2 sites📍 Chicago📍 Evanston Northwestern University · Tests: High level of signal manipulation, Low level of signal manipulation Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD) NCT06597942Phase 1, Phase 21 site📍 Los Angeles University of California, Los Angeles · Tests: TMS, Transcranial Magnetic Stimulation Sham Assess Fibrin in Brains With AD/ADRD NCT05336695Phase 1, Phase 21 site📍 Boston Massachusetts General Hospital · Tests: PET/MR Imaging, 64Cu-FBP8 Rifaximin SSD in Dementia Trial NCT06718686Phase 1, Phase 21 site📍 Richmond Jasmohan Bajaj · Tests: Rifaximin SSD 40 mg IR tablet, Placebo Autonomic Involvement in Patient With Cognitive Decline NCT06292741NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Sudoscan Validation of a Digital Intervention to Rehabilitate Cognitive Resources NCT07064226NA1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: RICORDO, Treatment as Usual (TAU) Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type NCT07066826Phase 2, Phase 31 site📍 Beijing Wanbangde Pharmaceutical Group Co., LTD · Tests: Huperzine A Controlled-Release Tablets, Donepezil hydrochloride tablets, Huperzine A controlled-release tablets placebo… Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort NCT07485387n/a1 site📍 Seoul Korea University Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis NCT06339190n/a2 sites📍 Box Hill📍 Wantirna Monash University · Tests: Venepuncture Physical Activity and Community EmPOWERment Project NCT06740162NA2 sites📍 Fayetteville📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: PACE Program A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease NCT07688213Phase 220 sites📍 Long Beach📍 Oakland📍 Naples Sanofi · Tests: SAR448851, Placebo Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type NCT06052254Phase 210 sites📍 Chino📍 Daytona Beach📍 Delray Beach Teikoku Pharma USA, Inc. · Tests: 12 cm2 - 2 Active DMTS Patches, 6 cm2 - 1 Active and 1 Placebo DMTS Patches, Placebo - 2 Placebo DMTS Patches Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study NCT07482072n/a1 site📍 Herlev Copenhagen University Hospital, Rigshospitalet · Tests: [18F]FDG PET, [11C]PIB Dominantly Inherited Alzheimer Network (DIAN) NCT00869817n/a26 sites📍 Jacksonville📍 Indianapolis📍 Boston Washington University School of Medicine Uppsala-Dalarna Dementia and Gait Project NCT05893524n/a2 sites📍 Falun📍 Uppsala Dalarna University · Tests: Timed Up-and-Go (TUG single-task), Timed Up-and-Go dual-task (TUGdt), Clinical functional assessment Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia NCT07251023Phase 312 sites📍 Kazan'📍 Moscow📍 Moscow Bigespas LTD · Tests: DMB-I (INN: Latrepirdine), Memantine Hydrochloride 20 MG, Placebo A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation NCT05552157Phase 2, Phase 337 sites📍 Birmingham📍 La Jolla📍 Los Angeles Washington University School of Medicine · Tests: Remternetug (SC), Matching Placebo (Remternetug) Using the EHR to Advance Genomic Medicine Across a Diverse Health System NCT06377033NA1 site📍 Philadelphia University of Pennsylvania · Tests: Behavioral nudge
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy